Dr. Joseph Mikhael discusses early signs, treatments and supportive care for multiple myeloma in an interview with CURE.

Action Month, created, according to the International Myeloma Foundation (IMF), “to draw attention to the disease and inspire ...

March has been declared Multiple Myeloma Month in BC following the efforts of an advocacy group in Abbotsford. Multiple ...

Johnson & Johnson is dropping a partnership with Genmab centered around a CD38 monoclonal antibody, prompting the latter ...

C4 Therapeutics shows promise in protein degraders but faces safety concerns and long timelines. Click here to find out why I ...

Multiple myeloma (MM) is a blood cancer that affects plasma cells in bone marrow. It’s a particularly insidious form of ...

Abecma is being jointly developed and commercialized in the U.S. as part of a co-development, co-promotion, and profit share ...

An elderly patient who was initially suspected of having antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) was instead diagnosed with multiple myeloma, according to a case report ...

Worship Walker County will hold its Women’s Breakfast on Friday, March 21 at 8:30 a.m. at Morning Pointe at Happy Valley. The ...

Patients with RA who have used b/tsDMARDs demonstrated similar risks for multiple myeloma when compared with those taking only csDMARDs.

Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial of idecabtagene vicleucel in patients with multiple myeloma.

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...